OMED Health partners with Aviva to support the digestive health of employees
Collaboration will evaluate the impact of the OMED solution on the digestive health and quality of life of participants in a workplace setting
28 Oct 2025
OMED Health, a UK-based business pioneering non-invasive breath analysis for gut health and part of Owlstone Medical, has announced a pilot as part of its longstanding collaboration with Aviva, a UK insurer.
The pilot, involving 75 Aviva employees, intends to demonstrate the value of the OMED Health solution in a workplace setting by addressing the significant impact of gastrointestinal (GI) conditions on employee health and workplace productivity. The study is expected to be completed within six months.
The pilot group of Aviva employees will receive access to OMED Health Plans, a CQC-registered service that guides individuals through personalized care pathways, including treatments and custom diet plans and supported by consultations with a licensed Owlstone medical doctor, to help them to gain control over their GI symptoms or conditions.
Each participant will also receive an OMED Health Breath Analyzer, a handheld medical device that accurately measures gases related to the microbiome, and a linked mobile app which collects vital symptom and dietary data. The Analyzer will be used to track progress through the pilot, and surveys will be provided to participants prior to and following the pilot to determine the direct impact of the Health Plan on their gut health and quality of life.
This initiative strongly supports the 'Fit for the Future: 10 Year Health Plan for England', which outlines three radical shifts for the NHS: from sickness to prevention, from analogue to digital, and from hospital to community. By improving employee health and reducing absenteeism, adoption of the OMED Health solution has the potential to contribute to the broader NHS ambition of enhancing productivity and supporting economic growth, while reducing the burden on the NHS by decreasing unnecessary visits to traditional healthcare settings through at-home diagnosis and management of disease.
Billy Boyle, co-founder and CEO at Owlstone Medical, said, "OMED Health was founded to better the diagnosis and management of digestive health by providing patients and doctors with access to transformational breath-based solutions and clinical care, meaningfully improving patients’ quality of life, both at work and at home. We intend for the OMED solution to become part of the standard of care, either from ourselves or through license partners, and are grateful to Aviva for the support and funding provided for this study which will help us to advance towards this goal.”